Collecting duct carcinoma (CDC) is an aggressive kidney cancer without effective treatment. Our study not only enhanced our ...

Researchers Develop Promising Therapy Treatment That Can Kill Glioblastoma Cells in Newly Discovered Brain Pathway Aug. 2, 2024 — A new pathway that is used by cancer cells to infiltrate the ...

induced Th1 immune responses [90] pDNA (β-gal) + pDNA (CCL19) Fibrosarcoma, MCA205 (β-gal) tumor cells Enhancement of a Th1-polarized immune response with substantial improvement of the ...

Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumor immunotherapy due to their unique ...

When monocytes differentiate in a Th1 immune environment ... this construct helps to conceptualize how TAMs and tumor cells influence one another, and how that interaction can be manipulated ...

The findings ... New Mechanism of Action Kills Cancer Cells Aug. 14, 2024 — Conventional cancer drugs work by triggering apoptosis, that is programmed cell death, in tumor cells. However ...

CLDN18-ARHGAP fusion gene of gastric cancer generates an immunogenic neoantigen, which induces neoantigen reactive T cells ...

However, depending on the type of lung cancer you have, cancer cells may grow and spread faster in some people than in others. For instance, small cell lung cancer (SCLC), which is a less common ...

A new research paper was published in Oncotarget titled, "A nanobody against the V-ATPase c subunit inhibits metastasis of ...

Turnstone Biologics is narrowing the focus of phase 1 trials of its lead tumor-infiltrating lymphocyte (TIL) therapy, with ...

Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumor immunotherapy due to their unique ...